Industry
Biotechnology
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
September 26, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Newsdesk
August 27, 2024 | 11:50 pm
Portfolio Pulse from Benzinga Newsdesk
August 19, 2024 | 12:33 pm
Portfolio Pulse from Benzinga Newsdesk
August 15, 2024 | 7:59 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 8:17 pm
Portfolio Pulse from Benzinga Newsdesk
May 30, 2024 | 9:56 am
Portfolio Pulse from Benzinga Newsdesk
May 13, 2024 | 9:12 pm
Portfolio Pulse from Benzinga Newsdesk
May 13, 2024 | 8:22 pm
Portfolio Pulse from Benzinga Newsdesk
April 08, 2024 | 9:36 pm
Portfolio Pulse from Benzinga Newsdesk
March 18, 2024 | 8:13 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.